Company news

Perseus Proteomics, Inc. news in 2026

Perseus Proteomics, Inc.'s news releases, calls and decks from 2026, newest first.

View company

Non-consolidated Financial Results for the Three Months Ended June 30, 2026 (Under Japanese GAAP)

August 13, 2026

Notice Regarding the Results of a Clinical Study in Patients Who Participated in the Phase I Clinical Trial of PPMX-T003 for Polycythemia Vera

July 1, 2026

(Amendments) Amendments to “Non-consolidated Summary of Financial Results for the Fiscal Year Ended March 31, 2026”

June 21, 2026

Decks in 2026